2012 American College of Cardiology Foundation/Society for Cardiovascular Angiography and Interventions Expert Consensus Document on Cardiac Catheterization Laboratory Standards update: A report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents

Journal of the American College of Cardiology

Volumn 59, Issue 24, 2012, Pages 2221-2305

  Bashore, Thomas M ^a,b   Balter, Stephen ^f   Barac, Ana ^a   Byrne, John G ^c   Cavendish, Jeffrey J ^a   Chambers, Charles E ^b   Hermiller, James Bernard ^a   Kinlay, Scott ^d   Landzberg, Joel S ^a   Laskey, Warren K ^a   McKay, Charles R ^a   Miller, Julie M ^a   Moliterno, David J ^e   Moore, John W M ^a   Oliver Mcneil, Sandra M ^a   Popma, Jeffrey J ^a   Tommaso, Carl L ^b  

^a AMERICAN COLLEGE OF CARDIOLOGY   (United States)

^b Society for Cardiovascular Angiography and Interventions Representative   (United States)

^c Society of Thoracic Surgeons Representative   (United States)

^d Society for Vascular Medicine Representative   (United States)

^e ACCF Task Force on Clinical Expert Consensus Documents Representative   (United States)

^f NONE

Author keywords

ACCF expert consensus document; catheter based coronary interventions; quality assurance; registries

Indexed keywords

APIXABAN; DABIGATRAN ETEXILATE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; MUSCLE RELAXANT AGENT; RIVAROXABAN; SEDATIVE AGENT; WARFARIN;

ADVERSE OUTCOME; ANGIOCARDIOGRAPHY; BLEEDING; BLOOD PRESSURE MEASUREMENT; CEREBROVASCULAR DISEASE; CLINICAL LABORATORY; CONSENSUS DEVELOPMENT; CORONARY HEMODYNAMICS; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DOPPLER ECHOCARDIOGRAPHY; DRUG HALF LIFE; DRUG USE; HEART CATHETERIZATION; HEART OUTPUT MEASUREMENT; HEART VENTRICULOGRAPHY; HOSPITALIZED CHILD; HUMAN; INOTROPISM; INTRACARDIAC ECHOCARDIOGRAPHY; MEDICAL EDUCATION; MEDICAL ETHICS; OUTCOME ASSESSMENT; OUTPATIENT CARE; PAIN ASSESSMENT; PARTIAL THROMBOPLASTIN TIME; PATIENT PREFERENCE; PATIENT SAFETY; PATIENT SELECTION; PEER REVIEW; PERCUTANEOUS CORONARY INTERVENTION; PERICARDIOCENTESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QUALITY CONTROL; RADIATION PROTECTION; RADIATION SAFETY; RADIOCARDIOGRAPHY; RESUSCITATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STROKE; VASCULAR RESISTANCE;

EID: 84861127537     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.02.010     Document Type: Article

References (313)

1. Bashore TM, Bates ER, Berger PB, et al. American College of Cardiology/Society for Cardiac Angiography and Interventions clinical expert consensus document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2001;37:2170-214. (Pubitemid 32549759)
2. American College of Cardiology Foundation. Manual for ACCF clinical expert consensus statement documents. 2008. Available at: http://www. cardiosource.org/Science-And-Quality/Practice-Guidelines-and-Quality-Standards/ ~media/Files/Science%20and%20Quality/Guidelines/Policies-Procedures/ CECD%20Writers%20Guide.ashx. Accessed March 16, 2012.
3. Levit K, Wier L, Stranges E, Ryan K, et al. HCUP Facts and Figures: Statistics on Hospital-Based Care in the United States, 2007. Rockville, MD: Agency for Healthcare Research and Quality, 2009. Available at: http://www.hcup-us.ahrq.gov/reports/ factsandfigures/2007/TOC-2007.jsp.
4. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119:480-6.
5. Nallamothu BK, Young J, Gurm HS, et al. Recent trends in hospital utilization for acute myocardial infarction and coronary revascularization in the United States. Am J Cardiol. 2007;99:749-53. (Pubitemid 46389372)
6. King SB III, Aversano T, Ballard WL, et al. ACCF/AHA/SCAI 2007 update of the clinical competence statement on cardiac interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Update the 1998 Clinical Competence Statement on Recommendations for the Assessment and Maintenance of Proficiency in Coronary Interventional Procedures). J Am Coll Cardiol. 2007;50:82-108.
7. Weintraub WS, McKay CR, Riner RN, et al., American College of Cardiology Database Committee. The American College of Cardiology National Database: progress and challenges. J Am Coll Cardiol. 1997;29:459-65. (Pubitemid 27059982)
8. Ammann P, Brunner-La Rocca HP, Angehrn W, et al. Procedural complications following diagnostic coronary angiography are related to the operator's experience and the catheter size. Catheter Cardiovasc Interv. 2003;59:13-8. (Pubitemid 36528791)
9. Roe MT, Messenger JC, Weintraub WS, et al. Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. J Am Coll Cardiol. 2010;56:254-63.
10. Singh M, Gersh BJ, Lennon RJ, et al. Outcomes of a system-wide protocol for elective and nonelective coronary angioplasty at sites without on-site surgery: the Mayo Clinic experience. Mayo Clin Proc. 2009;84:501-8.
11. Ross JS, Ho V, Wang Y, et al. Certificate of need regulation and cardiac catheterization appropriateness after acute myocardial infarction. Circulation. 2007;115:1012-9. (Pubitemid 46328295)
12. Fazel R, Krumholz HM, Bates ER, et al. Choice of reperfusion strategy at hospitals with primary percutaneous coronary intervention: a National Registry of Myocardial Infarction analysis. Circulation. 2009;120:2455-61.
13. Long KH, McMurtry EK, Lennon RJ, et al. Elective percutaneous coronary intervention without on-site cardiac surgery: clinical and economic implications. Med Care 2006;44:406-13. (Pubitemid 43755419)
14. Dehmer GJ, Blankenship J, Wharton TP Jr., et al. The current status and future direction of percutaneous coronary intervention without on-site surgical backup: an expert consensus document from the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2007;69:471-8. (Pubitemid 46363845)
15. Dehmer GJ, Kutcher MA, Dey SK, et al. Frequency of percutaneous coronary interventions at facilities without on-site cardiac surgical backup - a report from the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). Am J Cardiol. 2007;99:329-32. (Pubitemid 46149551)
16. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503-16. (Pubitemid 46588415)
17. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360:961-72.
18. O'Neill WW. A case against low-volume percutaneous coronary intervention centers. Circulation. 2009;120:546-8.
19. Carlsson J, James SN, Stahle E, et al. Outcome of percutaneous coronary intervention in hospitals with and without on-site cardiac surgery standby. Heart. 2007;93:335-8. (Pubitemid 46579524)
20. Djelmami-Hani M, Mouanoutoua M, Hashim A, et al. Elective percutaneous coronary intervention without on-site surgical backup: a community hospital experience. WMJ. 2007;106:481-5.
21. Klinke WP, Hui W. Percutaneous transluminal coronary angioplasty without on-site surgical facilities. Am J Cardiol. 1992;70:1520-5. (Pubitemid 23006062)
22. Zavala-Alarcon E, Cecena F, Ashar R, et al. Safety of elective - including "high risk"-percutaneous coronary interventions without onsite cardiac surgery. Am Heart J. 2004;148:676-83. (Pubitemid 39359167)
23. Tebbe U, Hochadel M, Bramlage P, et al. In-hospital outcomes after elective and non-elective percutaneous coronary interventions in hospitals with and without on-site cardiac surgery backup. Clin Res Cardiol. 2009;98:701-7.
24. Shiraishi J, Kohno Y, Sawada T, et al. In-hospital outcomes of primary percutaneous coronary interventions performed at hospitals with and without on-site coronary artery bypass graft surgery. Circ J. 2007;71:1208-12. (Pubitemid 47195334)
25. Peels JO, Hautvast RW, de Swart JB, et al. Percutaneous coronary intervention without on site surgical back-up: two-years registry of a large Dutch community hospital. Int J Cardiol. 2009;132:59-65.
26. Jokhi PP, Critoph C, Rozkovec A, et al. Is coronary angiography in unstable patients safe in district general hospitals without any on-site revascularisation? Int J Cardiol. 2005;105:147-51. (Pubitemid 41512480)
27. Gunalingam B, Wilkes N, Hill A, et al. Percutaneous coronary interventions without on-site cardiac surgery: a remote Australian experience. Heart Lung Circ. 2008;17:388-94.
28. Dellavalle A, Steffenino G, Ribichini F, et al. Elective coronary angioplasty with and without surgical standby: clinical and angiographic criteria for the selection of patients. Coron Artery Dis 1995;6:513-20.
29. Ting HH, Raveendran G, Lennon RJ, et al. A total of 1,007 percutaneous coronary interventions without onsite cardiac surgery: acute and long-term outcomes. J Am Coll Cardiol. 2006;47:1713-21.
30. Melberg T, Nilsen DW, Larsen AI, et al. Nonemergent coronary angioplasty without on-site surgical backup: a randomized study evaluating outcomes in low-risk patients. Am Heart J. 2006;152: 888-95. (Pubitemid 44632952)
31. Frutkin AD, Mehta SK, Patel T, et al. Outcomes of 1,090 consecutive, elective, nonselected percutaneous coronary interventions at a community hospital without onsite cardiac surgery. Am J Cardiol. 2008;101:53-7. (Pubitemid 350297199)
32. Singh PP, Singh M, Bedi US, et al. Outcomes of nonemergent percutaneous coronary intervention with and without on-site surgical backup: a meta-analysis. Am J Ther. 2011;18:e22-8.
33. Singh M, Holmes DR Jr., Dehmer GJ, et al. Percutaneous coronary intervention at centers with and without on-site surgery: a metaanalysis. JAMA. 2011;306:2487-94.
34. Ellis SG, Vandormael MG, Cowley MJ, et al., Multivessel Angioplasty Prognosis Study Group. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Circulation. 1990;82:1193-202.
35. Adversano T. Outcomes of Non-Primary PCI at Hospitals with and Without On-Site Cardiac Surgery: A Randomized Study. Slides presented at American Heart Association Scientific Sessions 2011; November 14, 2011; Orlando, FL. Available at: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/ documents/downloadable/ucm-433712.pdf. Accessed March 28, 2012.
36. Kutcher MA, Klein LW, Ou FS, et al. Percutaneous coronary interventions in facilities without cardiac surgery on site: a report from the National Cardiovascular Data Registry (NCDR). J Am Coll Cardiol. 2009;54:16-24.
37. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361:13-20. (Pubitemid 36050955)
38. Fox KA, Steg PG, Eagle KA, et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA. 2007;297:1892-900. (Pubitemid 46707843)
39. Nallamothu BK, Blaney ME, Morris SM, et al. Acute reperfusion therapy in ST-elevation myocardial infarction from 1994-2003. Am J Med. 2007;120:693-9.
40. Jacobs AK. Primary percutaneous coronary intervention without cardiac surgery on-site: coming to a hospital near you? Am Heart J. 2008;155:585-8. (Pubitemid 351410513)
41. Aguirre FV, Varghese JJ, Kelley MP, et al. Rural interhospital transfer of ST-elevation myocardial infarction patients for percutaneous coronary revascularization: the Stat Heart Program. Circulation. 2008;117:1145-52. (Pubitemid 351544065)
42. Pride YB, Canto JG, Frederick PD, et al. Outcomes among patients with ST-segment-elevation myocardial infarction presenting to interventional hospitals with and without on-site cardiac surgery. Circ Cardiovasc Qual Outcomes. 2009;2:574-82.
43. Aversano T, Aversano LT, Passamani E, et al. Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial. JAMA. 2002;287:1943-51. (Pubitemid 34309752)
44. Sanborn TA, Jacobs AK, Frederick PD, et al. Comparability of quality-of-care indicators for emergency coronary angioplasty in patients with acute myocardial infarction regardless of on-site cardiac surgery (report from the National Registry of Myocardial Infarction). Am J Cardiol. 2004;93:1335-9. (Pubitemid 38692458)
45. Wharton TP Jr., Grines LL, Turco MA, et al. Primary angioplasty in acute myocardial infarction at hospitals with no surgery on-site (the PAMI-No SOS study) versus transfer to surgical centers for primary angioplasty. J Am Coll Cardiol. 2004;43:1943-50. (Pubitemid 38686785)
46. Buckley JW, Bates ER, Nallamothu BK. Primary percutaneous coronary intervention expansion to hospitals without on-site cardiac surgery in Michigan: a geographic information systems analysis. Am Heart J. 2008;155:668-72.
47. Kushner FG, Hand M, Smith SC Jr., et al. 2009 focused updates: ACCF/AHA guidelines for the management of patients with STelevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2009;54:2205-41.
48. Jacobs AK, Antman EM, Ellrodt G, et al. Recommendation to develop strategies to increase the number of ST-segment-elevation myocardial infarction patients with timely access to primary percutaneous coronary intervention. Circulation. 2006;113:2152-63.
49. Casella G, Ottani F, Ortolani P, et al. Off-hour primary percutaneous coronary angioplasty does not affect outcome of patients with ST-segment elevation acute myocardial infarction treated within a regional network for reperfusion: the REAL (Registro Regionale Angioplastiche dell'Emilia-Romagna) registry. J Am Coll Cardiol Intv. 2011;4:270-8.
50. Jacobs AK. Regionalized care for patients with ST-elevation myocardial infarction: it's closer than you think. Circulation. 2006;113: 1159-61.
51. Jollis JG, Roettig ML, Aluko AO, et al. Implementation of a statewide system for coronary reperfusion for ST-segment elevation myocardial infarction. JAMA. 2007;298:2371-80. (Pubitemid 350190778)
52. Owen A. CARESS-in-AMI study. Lancet. 2008;371:1997-8. (Pubitemid 351799853)
53. Dimopoulos K, Dudek D, Piscione F, et al. Timing of events in STEMI patients treated with immediate PCI or standard medical therapy: implications on optimisation of timing of treatment from the CARESS-in-AMI trial. Int J Cardiol. 2012;154:275-81.
54. Cantor WJ, Fitchett D, Borgundvaag B, et al. Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med. 2009;360:2705-18.
55. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/ SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011;58:e44-122.
56. Terkelsen CJ, Sorensen JT, Maeng M, et al. System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention. JAMA. 2010;304:763-71.
57. Sikkel MB, Ruparelia N, Shirodaria C, et al. Can aggressive pharmacoinvasive therapy for ST elevation myocardial infarction achieve TIMI flow and survival comparable to primary angioplasty (abstr)? Heart. 2009;95:73.
58. King SB III, Walford G, for the New York State Cardiac Advisory Committee. Percutaneous coronary interventions (PCI) in New York state 2005-2007. Albany, NY: New York State Department of Health; April 2010. Available at: http://www.health.ny.gov/statistics/ diseases/cardiovascular/docs/ pci-2005-2007.pdf. Accessed March 28, 2012.
59. Di Mario C, Dudek D, Piscione F, et al. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial. Lancet. 2008;371:559-68. (Pubitemid 351232030)
60. Cantor WJ, Fitchett D, Borgundvaag B, et al. Rationale and design of the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI). Am Heart J. 2008;155:19-25. (Pubitemid 350237678)
61. Singh M, Rihal CS, Gersh BJ, et al. Twenty-five-year trends in in-hospital and long-term outcome after percutaneous coronary intervention: a single-institution experience. Circulation. 2007;115: 2835-41. (Pubitemid 46869670)
62. Johnson LW, Lozner EC, Johnson S, et al. Coronary arteriography 1984-1987: a report of the Registry of the Society for Cardiac Angiography and Interventions: results and complications. Cathet Cardiovasc Diagn. 1989;17:5-10. (Pubitemid 19112841)
63. Johnson LW, Krone R. Cardiac catheterization 1991: a report of the Registry of the Society for Cardiac Angiography and Interventions (SCA&I). Cathet Cardiovasc Diagn. 1993;28:219-20. (Pubitemid 23097004)
64. Patel MR, Peterson ED, Dai D, et al. Low diagnostic yield of elective coronary angiography. N Engl J Med. 2010;362:886-95.
65. Bonow RO, Masoudi FA, Rumsfeld JS, et al. ACC/AHA classification of care metrics: performance measures and quality metrics: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol. 2008;52:2113-7.
66. Scanlon PJ, Faxon DP, Audet AM, et al. ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/ American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). J Am Coll Cardiol. 1999; 33:1756-824.
67. Laskey W, Boyle J, Johnson LW, the Registry Committee of the Society for Cardiac Angiography & Interventions. Multivariable model for prediction of risk of significant complication during diagnostic cardiac catheterization. Cathet Cardiovasc Diagn. 1993; 30:185-90. (Pubitemid 23320266)
68. Folland ED, Oprian C, Giacomini J, et al. Complications of cardiac catheterization and angiography in patients with valvular heart disease. VA Cooperative Study on Valvular Heart Disease. Cathet Cardiovasc Diagn. 1989;17:15-21. (Pubitemid 19112843)
69. Roelke M, Smith AJ, Palacios IF. The technique and safety of transseptal left heart catheterization: the Massachusetts General Hospital experience with 1,279 procedures. Cathet Cardiovasc Diagn. 1994;32:332-9. (Pubitemid 24267468)
70. Baraldi-Junkins C, Levin HR, Kasper EK, et al. Complications of endomyocardial biopsy in heart transplant patients. J Heart Lung Transplant. 1993;12:63-7. (Pubitemid 23099861)
71. Yatskar L, Selzer F, Feit F, et al. Access site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: data from the National Heart, Lung, and Blood Institute Dynamic Registry. Catheter Cardiovasc Interv. 2007;69:961-6. (Pubitemid 46897929)
72. Rao SV, Ou FS, Wang TY, et al. Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry. J Am Coll Cardiol Intv. 2008;1:379-86.
73. Applegate RJ, Sacrinty MT, Kutcher MA, et al. Trends in vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention via the femoral artery, 1998 to 2007. J Am Coll Cardiol Intv. 2008;1:317-26. (Pubitemid 351804185)
74. Omran H, Schmidt H, Hackenbroch M, et al. Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study. Lancet. 2003; 361:1241-6. (Pubitemid 36428577)
75. Chambers J, Bach D, Dumesnil J, et al. Crossing the aortic valve in severe aortic stenosis: no longer acceptable? J Heart Valve Dis. 2004;13:344-6.
76. Hirshfeld JW Jr., Ellis SG, Faxon DP. Recommendations for the assessment and maintenance of proficiency in coronary interventional procedures: statement of the American College of Cardiology. J Am Coll Cardiol. 1998;31:722-43. (Pubitemid 28144144)
77. Block PC, Peterson ED, Krone R, et al. Identification of variables needed to risk adjust outcomes of coronary interventions: evidence-based guidelines for efficient data collection. J Am Coll Cardiol. 1998;32:275-82. (Pubitemid 28351073)
78. Kimmel SE, Berlin JA, Laskey WK. The relationship between coronary angioplasty procedure volume and major complications. JAMA. 1995;274:1137-42.
79. Jollis JG, Peterson ED, DeLong ER, et al. The relation between the volume of coronary angioplasty procedures at hospitals treating Medicare beneficiaries and short-term mortality. N Engl J Med. 1994;331:1625-9. (Pubitemid 24372062)
80. Hannan EL, Racz M, Ryan TJ, et al. Coronary angioplasty volume-outcome relationships for hospitals and cardiologists. JAMA. 1997; 277:892-8. (Pubitemid 27123949)
81. Kuntz RE, Normand SL. Measuring percutaneous coronary intervention quality by simple case volume. Circulation. 2005;112:1088-91. (Pubitemid 41216113)
82. Kimmel SE, Berlin JA, Strom BL, et al., the Registry Committee of the Society for Cardiac Angiography and Interventions. Development and validation of simplified predictive index for major complications in contemporary percutaneous transluminal coronary angioplasty practice. J Am Coll Cardiol. 1995;26:931-8.
83. Ellis SG. Coronary lesions at increased risk. Am Heart J. 1995;130: 643-6.
84. Baim DS, Detre K, Kent K. Problems in the development of new devices for coronary intervention: possible role for a multicenter registry. J Am Coll Cardiol. 1989;14:1389-92. (Pubitemid 19268697)
85. Dean LS, George CJ, Roubin GS, et al. Bailout and corrective use of Gianturco-Roubin flex stents after percutaneous transluminal coronary angioplasty: operator reports and angiographic core laboratory verification from the National Heart, Lung, and Blood Institute/New Approaches to Coronary Intervention Registry. J Am Coll Cardiol. 1997;29:934-40. (Pubitemid 27149564)
86. Lindsay J Jr., Pinnow EE, Pichard AD. Benchmarking operator performance in percutaneous coronary intervention: a novel approach using 30-day events. Catheter Cardiovasc Interv. 2001;52:139-45. (Pubitemid 32115122)
87. Laskey WK, Selzer F, Jacobs AK, et al. Importance of the postdischarge interval in assessing major adverse clinical event rates following percutaneous coronary intervention. Am J Cardiol. 2005;95: 1135-9. (Pubitemid 40616412)
88. Centers for Medicaid and Medicare Services. 2011 Physician Quality Reporting System. Available at: http://www.cms.gov/pqrs/downloads/ 2011-PhysQualRptg-ImplementationGuide-03312011.pdf. Accessed March 14, 2012.
89. Holmes DR Jr., Kip KE, Kelsey SF, et al. Cause of death analysis in the NHLBI PTCA Registry: results and considerations for evaluating long-term survival after coronary interventions. J Am Coll Cardiol. 1997;30:881-7. (Pubitemid 27435876)
90. Holmes DR, Selzer F, Johnston JM, et al. Modeling and risk prediction in the current era of interventional cardiology: a report from the National Heart, Lung, and Blood Institute Dynamic Registry. Circulation. 2003;107:1871-6. (Pubitemid 36444127)
91. Singh M, Rihal CS, Selzer F, et al. Validation of Mayo Clinic risk adjustment model for in-hospital complications after percutaneous coronary interventions, using the National Heart, Lung, and Blood Institute dynamic registry. J Am Coll Cardiol. 2003;42:1722-8. (Pubitemid 37433648)
92. Kip KE, Hollabaugh K, Marroquin OC, et al. The problem with composite end points in cardiovascular studies: the story of major adverse cardiac events and percutaneous coronary intervention. J Am Coll Cardiol. 2008;51:701-7. (Pubitemid 351222738)
93. Venkitachalam L, Kip KE, Selzer F, et al. Twenty-year evolution of percutaneous coronary intervention and its impact on clinical outcomes: a report from the National Heart, Lung, and Blood Institutesponsored, multicenter 1985-1986 PTCA and 1997-2006 Dynamic Registries. Circ Cardiovasc Interv. 2009;2:6-13.
94. Singh M, Rihal CS, Lennon RJ, et al. Bedside estimation of risk from percutaneous coronary intervention: the new Mayo Clinic risk scores. Mayo Clin Proc. 2007;82:701-8. (Pubitemid 46878093)
95. Anderson HV, Shaw RE, Brindis RG, et al. Risk-adjusted mortality analysis of percutaneous coronary interventions by American College of Cardiology/American Heart Association guidelines recommendations. Am J Cardiol. 2007;99:189-96. (Pubitemid 46072758)
96. Wu C, Hannan EL, Walford G, et al. A risk score to predict in-hospital mortality for percutaneous coronary interventions. J Am Coll Cardiol. 2006;47:654-60. (Pubitemid 43170859)
97. Kimmel SE, Berlin JA, Hennessy S, et al. Risk of major complications from coronary angioplasty performed immediately after diagnostic coronary angiography: results from the Registry of the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol. 1997;30:193-200. (Pubitemid 27357146)
98. Krone RJ, Shaw RE, Klein LW, et al. Ad hoc percutaneous coronary interventions in patients with stable coronary artery disease - a study of prevalence, safety, and variation in use from the American College of Cardiology National Cardiovascular Data Registry (ACCNCDR). Catheter Cardiovasc Interv. 2006;68:696-703. (Pubitemid 44721089)
99. Blankenship JC, Klein LW, Laskey WK, et al. Society for Cardiovascular Angiography and Interventions statement on ad hoc versus the separate performance of diagnostic cardiac catheterization and coronary intervention. Catheter Cardiovasc Interv. 2004;63:444-51. (Pubitemid 39578506)
100. Creager MA, Cooke JP, Olin JW, et al. Task force 11: training in vascular medicine and peripheral vascular catheter-based interventions. J Am Coll Cardiol. 2008;51:398-404.
101. Creager MA, Goldstone J, Hirshfeld JW Jr., et al. ACC/ACP/ SCAI/SVMB/SVS clinical competence statement on vascular medicine and catheter-based peripheral vascular interventions: a report of the American College of Cardiology/American Heart Association/ American College of Physician Task Force on Clinical Competence (ACC/ACP/SCAI/SVMB/SVS Writing Committee to Develop a Clinical Competence Statement on Peripheral Vascular Disease). J Am Coll Cardiol. 2004;44:941-57.
102. Heupler FA Jr., Chambers CE, Dear WE, et al. Guidelines for internal peer review in the cardiac catheterization laboratory. Laboratory Performance Standards Committee, Society for Cardiac Angiography and Interventions. Cathet Cardiovasc Diagn 1997;40:21-32.
103. Brindis RG, Dehmer GJ. Continuous quality improvement in the cardiac catheterization laboratory: are the benefits worth the cost and effort? Circulation 2006;113:767-70.
104. Dehmer GJ, Arani D, Noto T, et al. Lessons learned from the review of cardiac catheterization laboratories: a report from the Laboratory Survey Committee of the Society for Cardiac Angiography and Interventions. Catheter Cardiovasc Interv. 1999;46:24-31. (Pubitemid 29024508)
105. Wang MC, Hyun JK, Harrison M, et al. Redesigning health systems for quality: Lessons from emerging practices. Jt Comm J Qual Patient Saf. 2006;32:599-611.
106. Berwick DM, James B, Coye MJ. Connections between quality measurement and improvement. Med Care. 2003;41:I30-8.
107. Patel MR, Dehmer GJ, Hirshfeld JW, et al. ACCF/SCAI/STS/ AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, and Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2012;59:857-81.
108. Shaw RE, Anderson HV, Brindis RG, et al. Development of a risk adjustment mortality model using the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) experience: 1998-2000. J Am Coll Cardiol. 2002;39:1104-12. (Pubitemid 34267411)
109. Resnic FS, Welt FG. The public health hazards of risk avoidance associated with public reporting of risk-adjusted outcomes in coronary intervention. J Am Coll Cardiol. 2009;53:825-30.
110. Smith SC Jr., Feldman TE, Hirshfeld JW Jr., et al. ACC/AHA/ SCAI 2005 guideline update for percutaneous coronary intervention - summary article: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol. 2006;47:216-35.
111. Beller GA, Bonow RO, Fuster V. ACCF 2008 Recommendations for Training in Adult Cardiovascular Medicine Core Cardiology Training (COCATS 3) (revision of the 2002 COCATS Training Statement). J Am Coll Cardiol. 2008;51:335-8.
112. Marshall D, Chambers CE, Heupler F Jr. Performance of adult cardiac catheterization: nonphysicians should not function as independent operators - a position statement. Catheter Cardiovasc Interv. 1999;48:167-9. (Pubitemid 29458314)
113. Klein LW, Kolm P, Xu X, et al. A longitudinal assessment of coronary interventional program quality: a report from the American College of Cardiology-National Cardiovascular Data Registry. J Am Coll Cardiol Intv. 2009;2:136-43.
114. Brindis RG, Weintraub WS, Dudley RA. Volume as a surrogate for percutaneous coronary intervention quality: is this the right measuring stick? Am Heart J. 2003;146:932-4. (Pubitemid 37500761)
115. Jollis JG. The role of risk models in upholding standards for percutaneous coronary interventions. J Am Coll Cardiol Intv. 2009; 2:144-5.
116. Hendel RC, Budoff MJ, Cardella JF, et al. ACC/AHA/ACR/ASE/ ASNC/HRS/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR/SIR 2008 key data elements and definitions for cardiac imaging: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Cardiac Imaging). J Am Coll Cardiol. 2009;53:91-124.
117. Bates DW. The quality case for information technology in healthcare. BMC Med Inform Decis Mak 2002;2:1-9. (Pubitemid 38994340)
118. The Health Insurance Portability and Accountability Act of 1996 (HIPAA). Centers for Medicare and Medicaid Services. 2010. Available at: http://www.cms.gov/hipaaGenInfo/downloads/ HIPAAlaw.pdf. Accessed March 13, 2012.
119. Furuie SS, Bertozzo N, Yamaguti M, et al. A flexible storage architecture for large PACS. Comput Cardiol. 2002;29:405-8.
120. Marcheschi P, Ciregia A, Mazzarisi A, et al. A new approach to affordable and reliable cardiology PACS architecture using opensource technology. Comput Cardiol. 2009;36:537-40.
121. Elion JL, Becker T, Keller A, et al. Integrating the health care enterprise (IHE) interoperability for cardiology; year 1 demonstration. Comput Cardiol. 2005;691-4. (Pubitemid 46276756)
122. Judkins MP. Guidelines for electrical safety in the cardiac catheterization laboratory. Cathet Cardiovasc Diagn. 1984;10:299-301. (Pubitemid 14013465)
123. Laskey WK, Wondrow M, Holmes DR Jr. Variability in fluoroscopic X-ray exposure in contemporary cardiac catheterization laboratories. J Am Coll Cardiol. 2006;48:1361-4. (Pubitemid 44444866)
124. Thomas JD, Nissen SE. Digital storage and transmission of cardiovascular images: what are the costs, benefits and timetable for conversion? Heart. 1996;76:13-7. (Pubitemid 26267131)
125. Hilbel T, Reiter MA, Brockmeier K, et al. Advantages of a cardiac DICOM network server/writer for viewing and permanent CD-R archiving of cardiovascular x-ray angiography images. Comput Cardiol. 2000;27:649-52. (Pubitemid 32188044)
126. Nickoloff EL, Strauss KJ, Austin BT, et al. AAPM Report No. 70. Cardiac Catheterization Equipment Performance: Report of Task Group #17 Diagnostic X-ray Imaging Committee. January 2001. Madison, WI: Medical Physics.
127. Wondrow MA, Laskey WK, Hildner FJ, et al. Cardiac catheterization laboratory imaging quality assurance program. Catheter Cardiovasc Interv. 2001;52:59-66. (Pubitemid 32093927)
128. Laskey WK, Holmes DR, Kern MJ. Image quality assessment: a timely look. Catheter Cardiovasc Interv. 1999;46:125-6. (Pubitemid 29066614)
129. Williams SC, Schmaltz SP, Morton DJ, et al. Quality of care in U.S. hospitals as reflected by standardized measures, 2002-2004. N Engl J Med. 2005;353:255-64. (Pubitemid 41058325)
130. Anderson HV, Shaw RE, Brindis RG, et al. A contemporary overview of percutaneous coronary interventions. The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). J Am Coll Cardiol. 2002;39:1096-103. (Pubitemid 34267410)
131. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315-23. (Pubitemid 37186209)
132. Lemos PA, Serruys PW, van Domburg RT, et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation. 2004;109:190-5. (Pubitemid 38114138)
133. Ferguson JJ, Califf RM, Antman EM, et al. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA. 2004;292:45-54.
134. Stone GW, McLaurin BT, Cox DA, et al. Bivalirudin for patients with acute coronary syndromes. N Engl J Med. 2006;355:2203-16. (Pubitemid 44791162)
135. Aggarwal A, Dai D, Rumsfeld JS, et al. Incidence and predictors of stroke associated with percutaneous coronary intervention. Am J Cardiol. 2009;104:349-53.
136. Mehta SK, Frutkin AD, Lindsey JB, et al. Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry. Circ Cardiovasc Interv. 2009;2:222-9.
137. Novack V, Cutlip D, Kleiman N, et al. In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus - or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. J Am Coll Cardiol Intv. 2009;2:767-75.
138. Stone GW, Grines CL, Cox DA, et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med. 2002;346:957-66. (Pubitemid 34983245)
139. Abbott JD, Ahmed HN, Vlachos HA, et al. Comparison of outcome in patients with ST-elevation versus non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry). Am J Cardiol. 2007;100:190-5. (Pubitemid 47041983)
140. Stone GW, Witzenbichler B, Guagliumi G, et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med. 2008; 358:2218-30. (Pubitemid 351724451)
141. Steg PG, Fox KA, Eagle KA, et al. Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events. Eur Heart J. 2009;30:321-9.
142. Chen J, Krumholz HM, Wang Y, et al. Differences in patient survival after acute myocardial infarction by hospital capability of performing percutaneous coronary intervention: implications for regionalization. Arch Intern Med. 2010;170:433-9.
143. Epstein AJ, Rathore SS, Volpp KG, et al. Hospital percutaneous coronary intervention volume and patient mortality, 1998 to 2000: does the evidence support current procedure volume minimums? J Am Coll Cardiol. 2004;43:1755-62. (Pubitemid 38622510)
144. Tsang JS, Naughton PA, Leong S, et al. Virtual reality simulation in endovascular surgical training. Surgeon. 2008;6:214-20.
145. McGrath PD, Wennberg DE, Dickens JD Jr., et al. Relation between operator and hospital volume and outcomes following percutaneous coronary interventions in the era of the coronary stent. JAMA. 2000;284:3139-44. (Pubitemid 32039076)
146. Jollis JG, Peterson ED, Nelson CL, et al. Relationship between physician and hospital coronary angioplasty volume and outcome in elderly patients. Circulation. 1997;95:2485-91. (Pubitemid 27233113)
147. Cantor WJ, Hall R, Tu JV. Do operator volumes relate to clinical outcomes after percutaneous coronary intervention in the Canadian health care system? Am Heart J. 2006;151:902-8.
148. Mustafa MU, Cohen M, Zapotulko K, et al. The lack of a simple relation between physician's percutaneous coronary intervention volume and outcomes in the era of coronary stenting: a two-centre experience. Int J Clin Pract. 2005;59:1401-7. (Pubitemid 43922626)
149. Klein LW, Schaer GL, Calvin JE, et al. Does low individual operator coronary interventional procedural volume correlate with worse institutional procedural outcome? J Am Coll Cardiol. 1997;30:870-7.
150. Hannan EL, Wu C, Walford G, et al. Volume-outcome relationships for percutaneous coronary interventions in the stent era. Circulation. 2005;112:1171-9. (Pubitemid 41216124)
151. Kansagra SM, Curtis LH, Anstrom KJ, et al. Trends in operator and hospital procedure volume and outcomes for percutaneous transluminal coronary angioplasty, 1996 to 2001. Am J Cardiol. 2007;99: 339-43. (Pubitemid 46149555)
152. Malenka DJ, McGrath PD, Wennberg DE, et al., Northern New England Cardiovascular Disease Study Group. The relationship between operator volume and outcomes after percutaneous coronary interventions in high volume hospitals in 1994-1996: the northern New England experience. J Am Coll Cardiol. 1999;34:1471-80. (Pubitemid 29528659)
153. Moscucci M, Share D, Smith D, et al. Relationship between operator volume and adverse outcome in contemporary percutaneous coronary intervention practice: an analysis of a quality-controlled multicenter percutaneous coronary intervention clinical database. J Am Coll Cardiol. 2005;46:625-32. (Pubitemid 41132688)
154. Society of Cardiovascular Angiography and Interventions. New Report Shows Angioplasty Is Performed Half as Often as Previously Reported 2011. Available at: http://www.scai.org/press/ detail.aspx?cid=b767b7ea-fd20-461e-a1ee- edd958e3658b. Accessed December 15, 2011.
155. Post PN, Kuijpers M, Ebels T, et al. The relation between volume and outcome of coronary interventions: a systematic review and meta-analysis. Eur Heart J. 2010;31:1985-92.
156. Srinivas VS, Hailpern SM, Koss E, et al. Effect of physician volume on the relationship between hospital volume and mortality during primary angioplasty. J Am Coll Cardiol. 2009;53:574-9.
157. Kumbhani DJ, Cannon CP, Fonarow GC, et al. Association of hospital primary angioplasty volume in ST-segment elevation myocardial infarction with quality and outcomes. JAMA. 2009;302:2207-13.
158. Levine G, Bates ER, Blankenship JC, et al. ACCF/AHA/SCAI guidelines for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2011;58:e44-122.
159. Vakili BA, Brown DL. Relation of total annual coronary angioplasty volume of physicians and hospitals on outcomes of primary angioplasty for acute myocardial infarction (data from the 1995 Coronary Angioplasty Reporting System of the New York State Department of Health). Am J Cardiol. 2003;91:726-8. (Pubitemid 36287469)
160. Vakili BA, Kaplan R, Brown DL. Volume-outcome relation for physicians and hospitals performing angioplasty for acute myocardial infarction in New York state. Circulation. 2001;104:2171-6. (Pubitemid 33043295)
161. Politi A, Galli M, Zerboni S, et al. Operator volume and outcomes of primary angioplasty for acute myocardial infarction in a single high-volume centre. J Cardiovasc Med (Hagerstown). 2006;7:761-7. (Pubitemid 44454832)
162. Ellis SG, Weintraub W, Holmes D, et al. Relation of operator volume and experience to procedural outcome of percutaneous coronary revascularization at hospitals with high interventional volumes. Circulation. 1997;95:2479-84. (Pubitemid 27233112)
163. Shook TL, Sun GW, Burstein S, et al. Comparison of percutaneous transluminal coronary angioplasty outcome and hospital costs for low-volume and high-volume operators. Am J Cardiol. 1996;77: 331-6. (Pubitemid 26061161)
164. Grassman ED, Johnson SA, Krone RJ. Predictors of success and major complications for primary percutaneous transluminal coronary angioplasty in acute myocardial infarction. An analysis of the 1990 to 1994 Society for Cardiac Angiography and Interventions registries. J Am Coll Cardiol. 1997;30:201-8. (Pubitemid 27357147)
165. Hamad N, Pichard AD, Lyle HR, et al. Results of percutaneous transluminal coronary angioplasty by multiple, relatively low frequency operators: 1986-1987 experience. Am J Cardiol. 1988; 61:1229-31.
166. NHS Information Centre for Health and Social Care. Audit of angioplasty procedures 2009: the 2009 report of the National Audit of Percutaneous Coronary Intervention in the United Kingdom for the audit period between January 2008 and December 2008. Report No. IC17020110. Available at: http://www.ic.nhs.uk/ webfiles/Services/NCASP/audits%20and%20reports/ NHS%20IC%20PCI%20AUDIT%202009%20INTERACTIVE.pdf. Accessed March 13, 2012.
167. Dawkins KD, Gershlick T, de BelderMet al. Percutaneous coronary intervention: recommendations for good practice and training. Heart. 2005;91 Suppl 6:vi1-27.
168. Brown DL. Analysis of the institutional volume-outcome relations for balloon angioplasty and stenting in the stent era in California. Am Heart J. 2003;146:1071-6. (Pubitemid 37500783)
169. Jacobs AK, Babb JD, Hirshfeld JW Jr., et al. Task force 3: training in diagnostic and interventional cardiac catheterization. J Am Coll Cardiol. 2008;51:355-61.
170. Levin DC, Becker GJ, Dorros G, et al. Training standards for physicians performing peripheral angioplasty and other percutaneous peripheral vascular interventions. A statement for health professionals from the Special Writing Group of the Councils on Cardiovascular Radiology, Cardio-Thoracic and Vascular Surgery, and Clinical Cardiology, the American Heart Association. J Vasc Interv Radiol. 2003;14:S359-61.
171. Patel AD, Gallagher AG, Nicholson WJ, et al. Learning curves and reliability measures for virtual reality simulation in the performance assessment of carotid angiography. J Am Coll Cardiol. 2006;47: 1796-802.
172. Feldman T. A conversation with Dr. Ted Feldman: interventional treatment of structural heart disease. Interview by Ziyad Hijazi. Catheter Cardiovasc Interv. 2008;71:1002-5. (Pubitemid 351951332)
173. Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). J Am Coll Cardiol. 2008;52:e1-121.
174. Ruiz CE, Feldman TE, Hijazi ZM, et al. Interventional fellowship in structural and congenital heart disease for adults. Catheter Cardiovasc Interv. 2010;76:E90-105.
175. Herrmann HC, Baxter S, Ruiz CE, et al. Results of the Society of Cardiac Angiography and Interventions survey of physicians and training directors on procedures for structural and valvular heart disease. Catheter Cardiovasc Interv. 2010;76:E106-10.
176. Hirshfeld JW Jr., Banas JS Jr., Brundage BH, et al. American College of Cardiology training statement on recommendations for the structure of an optimal adult interventional cardiology training program: a report of the American College of Cardiology task force on clinical expert consensus documents. J Am Coll Cardiol. 1999;34:2141-7. (Pubitemid 30002678)
177. Patel JH, Mathew ST, Hennebry TA. Transcatheter aortic valve replacement: a potential option for the nonsurgical patient. Clin Cardiol. 2009;32:296-301.
178. Rihal CS, Nishimura RA, Holmes DR Jr. Percutaneous balloon mitral valvuloplasty: the learning curve. Am Heart J. 1991;122: 1750-6.
179. Sanchez PL, Harrell LC, Salas RE, et al. Learning curve of the Inoue technique of percutaneous mitral balloon valvuloplasty. Am J Cardiol. 2001;88:662-7. (Pubitemid 32831100)
180. Chambers CE, Eisenhauer MD, McNicol LB, et al. Infection control guidelines for the cardiac catheterization laboratory: society guidelines revisited. Catheter Cardiovasc Interv. 2006;67:78-86. (Pubitemid 43062613)
181. Gerberding JL, Littell C, Tarkington A, et al. Risk of exposure of surgical personnel to patients' blood during surgery at San Francisco General Hospital. N Engl J Med. 1990;322:1788-93. (Pubitemid 20194658)
182. Protection against viral hepatitis. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep. 1990;39:1-26.
183. Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients undergoing elective procedures: a report by the American Society of Anesthesiologist Task Force on Preoperative Fasting. Anesthesiology. 1999;90:896-905.
184. Marks JG Jr., Belsito DV, DeLeo VA, et al. North American Contact Dermatitis Group patch-test results, 1998 to 2000. Am J Contact Dermat. 2003;14:59-62. (Pubitemid 36988512)
185. Wertman B, Azarbal B, Riedl M, et al. Adverse events associated with nickel allergy in patients undergoing percutaneous atrial septal defect or patent foramen ovale closure. J Am Coll Cardiol. 2006;47: 1226-7.
186. Reddy BT, Patel JB, Powell DL, et al. Interatrial shunt closure devices in patients with nickel allergy. Catheter Cardiovasc Interv. 2009;74:647-51.
187. Ziakas AG, Koskinas KC, Gavrilidis S, et al. Radial versus femoral access for orally anticoagulated patients. Catheter Cardiovasc Interv. 2010;76:493-9.
188. Hirsh J, Guyatt G, Albers GW, et al. Executive summary: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest. 2008;133:71S-109.
189. Stangier J, Clemens A, Pharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor. Clin Appl Thromb Hemost. 2009;15 Suppl 1:9S-16S.
190. RELY Trial Emergency Information Elective Surgery-Dabigatran Arms. RELY Trial Emergency Information. 2011. Available at: rely-trial.com/RelyWeb/ resources/jsp/emergency/surgery.jsp. Accessed March 13, 2012.
191. Schirmer SH, Baumhakel M, Neuberger HR, et al. Novel anticoagulants for stroke prevention in atrial fibrillation: current clinical evidence and future developments. J Am Coll Cardiol. 2010;56: 2067-76.
192. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-70. (Pubitemid 29135798)
193. Maeder M, Klein M, Fehr T, et al. Contrast nephropathy: review focusing on prevention. J Am Coll Cardiol. 2004;44:1763-71. (Pubitemid 39424073)
194. Harjai KJ, Raizada A, Shenoy C, et al. A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system. Am J Cardiol. 2008;101:812-9.
195. Marenzi G, Assanelli E, Campodonico J, et al. Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. Ann Intern Med. 2009; 150:170-7.
196. Laskey WK, Jenkins C, Selzer F, et al. Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. J Am Coll Cardiol. 2007;50:584-90. (Pubitemid 47199002)
197. Gurm HS, Smith DE, Berwanger O, et al. Contemporary use and effectiveness of N-acetylcysteine in preventing contrast-induced nephropathy among patients undergoing percutaneous coronary intervention. J Am Coll Cardiol Intv. 2012;5:98-104.
198. Boyden TF, Gurm HS. Does gadolinium-based angiography protect against contrast-induced nephropathy? A systematic review of the literature. Catheter Cardiovasc Interv. 2008;71:687-93. (Pubitemid 351550413)
199. Briguori C, Airoldi F, D'Andrea D, et al. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation. 2007; 115:1211-7. (Pubitemid 46594764)
200. Lee PT, Chou KJ, Liu CP, et al. Renal protection for coronary angiography in advanced renal failure patients by prophylactic hemodialysis. A randomized controlled trial. J Am Coll Cardiol. 2007;50: 1015-20.
201. Khanal S, Attallah N, Smith DE, et al. Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions. Am J Med. 2005;118:843-9. (Pubitemid 41097461)
202. Aspelin P, Aubry P, Fransson SG, et al. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med. 2003;348: 491-9. (Pubitemid 36159884)
203. Reed M, Meier P, Tamhane UU, et al. The relative renal safety of iodixanol compared with low-osmolar contrast media: a metaanalysis of randomized controlled trials. J Am Coll Cardiol Intv. 2009;2:645-54.
204. Schweiger MJ, Chambers CE, Davidson CJ, et al. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures. Catheter Cardiovasc Interv. 2007;69:135-40. (Pubitemid 46052605)
205. McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol. 2008;51:1419-28. (Pubitemid 351471786)
206. Nayak KR, White AA, Cavendish JJ, et al. Anaphylactoid reactions to radiocontrast agents: prevention and treatment in the cardiac catheterization laboratory. J Invasive Cardiol. 2009;21:548-51.
207. Heupler FA Jr., Members of the Laboratory Performance Standards Committee of the Society for Cardiac Angiography and Interventions. Guidelines for performing angiography in patients taking metformin. Cathet Cardiovasc Diagn. 1998;43:121-3.
208. Centers for Disease Control and Prevention. Radiation and Pregnancy: A Fact Sheet for Clinicians. Available at: http:// www.bt.cdc.gov/radiation/ prenatalphysician.asp. Accessed February 15, 2011.
209. Garrett PD, Eckart RE, Bauch TD, et al. Fluoroscopic localization of the femoral head as a landmark for common femoral artery cannulation. Catheter Cardiovasc Interv. 2005;65:205-7. (Pubitemid 40791513)
210. Rao SV, Ou FS, Wang TY, et al. Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry. J Am Coll Cardiol Intv. 2008;1:379-86.
211. Talreja DR, Nishimura RA, Oh JK, et al. Constrictive pericarditis in the modern era: novel criteria for diagnosis in the cardiac catheterization laboratory. J Am Coll Cardiol. 2008;51:315-9.
212. Kern MJ, Samady H. Current concepts of integrated coronary physiology in the catheterization laboratory. J Am Coll Cardiol. 2010;55:173-85.
213. Pijls NH, van Schaardenburgh P, Manoharan G, et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. J Am Coll Cardiol. 2007;49:2105-11. (Pubitemid 46771047)
214. Pijls NH, Fearon WF, Tonino PA, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol. 2010;56:177-84.
215. Romaguera R, Wakabayashik, Laynez-Comicero A, et al. Association between bleeding severity and long term mortality in patients experiencing vascular complications after percutaneous intervention. Am J Cardiol. 2012;109:75-81.
216. Tobis J, Azarbal B, Slavin L. Assessment of intermediate severity coronary lesions in the catheterization laboratory. J Am Coll Cardiol. 2007;49:839-48. (Pubitemid 46275353)
217. Tonino PA, De Bruyne B, Pijls NH et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009;360:213-24.
218. White CW, Wright CB, Doty DB, et al. Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis? N Engl J Med. 1984;310:819-24. (Pubitemid 14167762)
219. Simonneau G, Galie N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2004;43:5S-12S. (Pubitemid 38759712)
220. Humbert M, Morrell NW, Archer SL, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43:13S-24S. (Pubitemid 38759713)
221. Barst RJ, Gibbs JS, Ghofrani HA, et al. Updated evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol. 2009;54:S78-84.
222. Balzer DT, Kort HW, Day RW, et al. Inhaled Nitric Oxide as a Preoperative Test (INOP Test I): the INOP Test Study Group. Circulation. 2002;106:I76-81.
223. Nishimura RA, Grantham JA, Connolly HM, et al. Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function: the clinical utility of the dobutamine challenge in the catheterization laboratory. Circulation. 2002;106:809-13.
224. Bergler-Klein J, Mundigler G, Pibarot P, et al. B-type natriuretic peptide in low-flow, low-gradient aortic stenosis: relationship to hemodynamics and clinical outcome: results from the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) study. Circulation. 2007;115:2848-55. (Pubitemid 46869672)
225. Tribouilloy C, Levy F, Rusinaru D, et al. Outcome after aortic valve replacement for low-flow/low-gradient aortic stenosis without contractile reserve on dobutamine stress echocardiography. J Am Coll Cardiol. 2009;53:1865-73.
226. Sjauw KD, Engstrom AE, Vis MM, et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J. 2009;30:459-68.
227. Cheng JM, den Uil CA, Hoeks SE, et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J. 2009;30:2102-8.
228. Mintz GS, Nissen SE, Anderson WD, et al. American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2001;37:1478-92.
229. Batkoff BW, Linker DT. Safety of intracoronary ultrasound: data from a Multicenter European Registry. Cathet Cardiovasc Diagn. 1996;38:238-41. (Pubitemid 26230934)
230. Bangalore S, Arora N, Resnic FS. Vascular closure device failure: frequency and implications: a propensity-matched analysis. Circ Cardiovasc Interv. 2009;2:549-56.
231. Turi ZG. An evidence-based approach to femoral arterial access and closure. Rev Cardiovasc Med. 2008;9:7-18.
232. Patel MR, Jneid H, Derdeyn CP, et al. Arteriotomy closure devices for cardiovascular procedures: a scientific statement from the American Heart Association. Circulation. 2010;122:1882-93.
233. Krasuski RA, Wang A, Ross C, et al. Trained and supervised physician assistants can safely perform diagnostic cardiac catheterization with coronary angiography. Catheter Cardiovasc Interv. 2003; 59:157-60. (Pubitemid 36665943)
234. Hirsch R. The hybrid cardiac catheterization laboratory for congenital heart disease: from conception to completion. Catheter Cardiovasc Interv. 2008;71:418-28. (Pubitemid 351428168)
235. Sikkink CJ, Reijnen MM, Zeebregts CJ. The creation of the optimal dedicated endovascular suite. Eur J Vasc Endovasc Surg. 2008;35: 198-204. (Pubitemid 351163077)
236. ten Cate G, Fosse E, Hol PK. Integrating surgery and radiology in one suite: a multicenter study. J Vasc Surg. 2008;40:494-9. (Pubitemid 39165025)
237. U.S. Department of Veterans Affairs. TIL-Design Guides (PG-18- 12)/surgical Series/Surgical Service/Section 2: Narrative. Office of Construction and Facilities Management, 2005. Available at: http:// www.cfm.va.gov/til/dGuide.asp. Accessed March 13, 2012.
238. American College of Physicians. Ethics manual. Fourth edition. Ann Intern Med. 1998;128:576-94.
239. American College of Physicians. American College of Physicians ethics manual. Part 1: history; the patient; other physicians. Ann Intern Med. 1989;111:245-52.
240. Parmley WW, Passamani ER, Lo B. 29th Bethesda Conference. Ethics in Cardiovascular Medicine (1997). Introduction. J Am Coll Cardiol. 1998;31:917-5.
241. American College of Physicians. American College of Physicians Ethics Manual. Part 2: the physician and society; research; life-sustaining treatment; other issues. Ann Intern Med. 1989;111:327-35.
242. 21st Bethesda Conference: ethics in cardiovascular medicine. October 5-6, 1989, Bethesda, Maryland. J Am Coll Cardiol. 1990;16:1-36.
243. Pepine CJ, Allen HD, Bashore TM, et al. American College of Cardiology/American Heart Association Ad Hoc Task Force on Cardiac Catheterization. ACC/AHA guidelines for cardiac catheterization and cardiac catheterization laboratories. Circulation. 1991;84:2213-47.
244. Blunt J, Savulescu J, Watson AJ. Meeting the challenges facing research ethics committees: some practical suggestions. BMJ. 1998; 316:58-61. (Pubitemid 28019875)
245. Hyman DA, Williamson JV. Fraud and abuse. Setting the limits on physicians' entrepreneurship. N Engl J Med. 1989;320:1275-8. (Pubitemid 19128127)
246. Todd JS, Horan JK. Physician referral - the AMA view. JAMA. 1989;262:395-6. (Pubitemid 19182847)
247. Stark FH. Physicians' conflicts in patient referrals. JAMA. 1989;262:397.
248. Relman AS. Dealing with conflicts of interest. N Engl J Med. 1985;313:749-51.
249. Omnibus Budget Reconciliation Act of 1993 (Public Law 103-66). Health Care Financ Rev. 1993 Fall;15:177-216.
250. Omnibus Budget Reconciliation Act of 1989, Public Law 101-239. Health Care Financ Rev. 1990 Fall;12:105-15.
251. Patient Protection and Affordable Care Act. Health-Related Portions of the Health Care and Education Reconciliation Act of 2010. Available at: http://housedocs.house.gov/energycommerce/ ppacacon.pdf. Accessed March 15, 2011.
252. Blankenship JC, Mishkel GJ, Chambers CE, et al. Ad hoc coronary intervention. Catheter Cardiovasc Interv. 2000;49:130-4. (Pubitemid 30075533)
253. Di Mario C. Informed consent in interventional cardiology. Euro-Intervention. 2009;5:415-6.
254. Coyle SL. Physician-industry relations. Part 1: individual physicians. Ann Intern Med. 2002;136:396-402. (Pubitemid 34183999)
255. Coyle SL. Physician-industry relations. Part 2: organizational issues. Ann Intern Med. 2002;136:403-6. (Pubitemid 34184000)
256. Hirshfeld JW Jr., Balter S, Brinker JA, et al. ACCF/AHA/HRS/ SCAI clinical competence statement on physician knowledge to optimize patient safety and image quality in fluoroscopically guided invasive cardiovascular procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training. J Am Coll Cardiol. 2004;44:2259-82. (Pubitemid 39576054)
257. National Council on Radiation Protection and Measurements. NCRP Report No. 168 - Radiation dose management for fluorscopically-guided interventional procedures. 2010. Available at: http://www.ncrppublications.org/Reports/168. Accessed March 14, 2012.
258. Balter S, Cusma JT, O'Hara MD, et al. Interventional Fluoroscopy. New York, NY: John Wiley & Sons, 2001.
259. Moore R. Imaging Principles of Cardiac Angiography. Rockville, Md: Aspen, 1993:143.
260. International Electrotechnical Commission. IEC Report 60601. Medical electrical equipment-part 2-43: particular requirements for the safety of x-ray equipment for interventional procedures. 2000. Available at: http://engineers.ihs.com/document/abstract/VPNUM AAAAAAAAAAA. Accessed March 14, 2012.
261. United States Food and Drug Administration. Performance standards for ionizing radiation emitting products. Fluoroscopy equipment. 21 CFR Part 1020.32. 2008. Available at: http://www.accessdata. fda.gov/scripts/cdrh/cfdocs/ cfcfr/CFRSearch.cfm. Accessed March 14, 2012.
262. United States Food and Drug Administration. Resource Manual for Compliance of Test Parameters of Diagnostic X-Ray Systems. 2010. Available at: http://www.fda.gov/Radiation-EmittingProducts/ RadiationEmittingProductsandProcedures/MedicalImaging/ MedicalXRays/ucm115361. htm. Accessed February 10, 2009.
263. Chida K, Inaba Y, Saito H, et al. Radiation dose of interventional radiology system using a flat-panel detector. AJR Am J Roentgenol. 2009;193:1680-5.
264. Holmes DR Jr., Laskey WK, Wondrow MA, et al. Flat-panel detectors in the cardiac catheterization laboratory: revolution or evolution - what are the
265. NEMA Standards Publication XR 21-2000. Characteristics of and test procedures for a phantom to benchmark cardiac fluoroscopic and photographic performance. NEMA Standards Publication. 2010. Available at: http://www.nema.org/stds/xr21.cfm. Accessed March 14, 2012.
266. Turi ZG. Whom do you trust? Misguided faith in the catheter - or Doppler-derived aortic valve gradient. Catheter Cardiovasc Interv. 2005;65:180-2. (Pubitemid 40791507)
267. Hall EJ. Radiology for the Radiologist. 5th edition. Philadelphia, PA: Lipincott, Williams & Wilkins, 2000.
268. Limacher MC, Douglas PS, Germano G, et al. ACC expert consensus document. Radiation safety in the practice of cardiology. J Am Coll Cardiol. 1998;31:892-913. (Pubitemid 28186430)
269. National Research Council. Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2. Washington, DC: The National Academies Press, 2006. Available at: http://www. nap.edu/openbook.php?record-id= 11340&page=R1. Accessed March 14, 2012.
270. International Commission on Radiological Protection. Radiological Protection in Medicine. ICRP Publication 105. Ann ICRP. 2010. Available at: www.icrp.org. Accessed March 14, 2012.
271. International Commission on Radiological Protection. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 103. Ann ICRP. 2010. Available at: http:// www.icrp.org/ publication.asp?id=ICRP%20Publication%20103. Accessed March 14, 2012.
272. National Council on Radiation Protection and Measurements. Limitation of Exposure to Ionizing Radiation, NCRP Report No. 116. Bethesda, MD: National Council on Radiation Protection and Measurements, 1993.
273. Shope TB. Radiation-induced skin injuries from fluoroscopy. Radiographics. 1996;16:1195-9. (Pubitemid 126448478)
274. Wagner LK, McNeese MD, Marx MV, et al. Severe skin reactions from interventional fluoroscopy: case report and review of the literature. Radiology. 1999;213:773-6.
275. Vano E, Arranz L, Sastre JM, et al. Dosimetric and radiation protection considerations based on some cases of patient skin injuries in interventional cardiology. Br J Radiol. 1998;71:510-6. (Pubitemid 28243072)
276. Valentin J. Avoidance of radiation injuries from medical interventional procedures. Ann ICRP. 2000;30:7-67. (Pubitemid 32664097)
277. National Council on Radiation Protection and Measurements. NCRP Report No. 122 - Use of personal monitors to estimate effective dose equivalent and effective dose to workers for external exposure to low LET radiation. 1995. Available at: http:// www.ncrppublications.org/Reports/122. Accessed March 14, 2012.
278. Chambers CE. Radiation safety program for the cardiac catheterization laboratory. Catheter Cardiovasc Interv. 2011;77:546-56.
279. Deleted in proof.
280. Martin CJ. Effective dose: how should it be applied to medical exposures? Br J Radiol. 2007;80:639-47. (Pubitemid 47517809)
281. Neofotistou V. Review of patient dosimetry in cardiology. Radiat Prot Dosimetry. 2001;94:177-82. (Pubitemid 32433158)
282. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and effects of ionizing radiation. UNSCEAR 1993 report to the General Assembly. 1993. Available at: http:// www.unscear.org/unscear/en/publications/ 1993.html. Accessed March 14, 2012.
283. Ciraj-Bjelac O, Rehani MM, Sim KH, et al. Risk for radiation-induced cataract for staff in interventional cardiology: is there reason for concern? Catheter Cardiovasc Interv. 2010;76:826-34.
284. Gerber TC, Carr JJ, Arai AE, et al. Ionizing radiation in cardiac imaging: a science advisory from the American Heart Association Committee on Cardiac Imaging of the Council on Clinical Cardiology and Committee on Cardiovascular Imaging and Intervention of the Council on Cardiovascular Radiology and Intervention. Circulation. 2009;119:1056-65.
285. Einstein AJ, Moser KW, Thompson RC, et al. Radiation dose to patients from cardiac diagnostic imaging. Circulation. 2007;116: 1290-305. (Pubitemid 47517541)
286. Efstathopoulos EP, Karvouni E, Kottou S, et al. Patient dosimetry during coronary interventions: a comprehensive analysis. Am Heart J. 2004;147:468-75. (Pubitemid 38880867)
287. Bacher K, Bogaert E, Lapere R, et al. Patient-specific dose and radiation risk estimation in pediatric cardiac catheterization. Circulation. 2005;111:83-9. (Pubitemid 40070848)
288. Lickfett L, Mahesh M, Vasamreddy C, et al. Radiation exposure during catheter ablation of atrial fibrillation. Circulation. 2004;110: 3003-10. (Pubitemid 39491990)
289. Livingstone RS, Chandy S, Peace BS, et al. Audit of radiation dose during balloon mitral valvuloplasty procedure. J Radiol Prot. 2006; 26:397-404.
290. Balter S, Hopewell JW, Miller DL, et al. Fluoroscopically guided interventional procedures: a review of radiation effects on patients' skin and hair. Radiology. 2010;254:326-41.
291. Balter S. Stray radiation in the cardiac catheterisation laboratory. Radiat Prot Dosimetry. 2001;94:183-8. (Pubitemid 32433159)
292. Kim KP, Miller DL, Balter S, et al. Occupational radiation doses to operators performing cardiac catheterization procedures. Health Phys. 2008;94:211-27. (Pubitemid 351643132)
293. Johnson LW, Moore RJ, Balter S. Review of radiation safety in the cardiac catheterization laboratory. Cathet Cardiovasc Diagn. 1992; 25:186-94.
294. Judkins MP. Guidelines for radiation protection in the cardiac catheterization laboratory. Cathet Cardiovasc Diagn. 1984;10:87-92. (Pubitemid 14142027)
295. National Council on Radiation Protection and Measurements. NCRP Report No. 107 - Implementation of the principle of as low as reasonably achievable (ALARA) for medical and dental personnel. 1990. Available at: http://www.ncrppublications.org/Reports/107. Accessed March 14, 2012.
296. Society for Cardiovascular Angiography and Interventions. Quality Management in the Cardiac Catheterization Laboratory. 1999. Available at: http://www.scai.org/Publications/Guidelines. aspx#1999. Accessed March 14, 2012.
297. Heupler FA, Jr., al-Hani AJ, Dear WE, Laboratory Performance Standards Committee of the Society for Cardiac Angiography & Interventions. Guidelines for continuous quality improvement in the cardiac catheterization laboratory. Cathet Cardiovasc Diagn. 1993; 30:191-200.
298. U.S. Nuclear Regulatory Commission. United States Nuclear Regulatory Commission: standards for protection against radiation. Washington, DC: NRC, 1996; 10 CFR Part 20. (1996).
299. Holmes DR, Wondrow M, Stueve R, et al. Variability of radiation output dynamic range in modern cardiac catheterization imaging systems. Cathet Cardiovasc Diagn. 1998;44:443-8. (Pubitemid 28359974)
300. International Atomic Energy Agency. Optimization of radiation protection in cardiology. International Atomic Energy Agency. 2010. Available at: https://rpop.iaea.org/Lectures/L09/. Accessed March 14, 2012.
301. International Commission on Radiological Protection. Interventional procedures-avoiding radiation injuries. ICRP Publication 85. Ann ICRP. 2010. Available at: http://www.icrp.org/downloadDoc.asp?document=docs/ICRP-85- Interventional-s.pps. Accessed March 14, 2012.
302. American Academy of Pediatrics. Guidelines for pediatric cardiovascular centers. Pediatrics. 2002;109:544-9.
303. Hijazi ZM, Awad SM. Pediatric cardiac interventions. J Am Coll Cardiol Intv. 2008;1:603-11.
304. Inglessis I, Landzberg MJ. Interventional catheterization in adult congenital heart disease. Circulation. 2007;115:1622-33. (Pubitemid 46648648)
305. Beekman RH III, Hellenbrand WE, Lloyd TR, et al. ACCF/AHA/ AAP recommendations for training in pediatric cardiology. Task force 3: training guidelines for pediatric cardiac catheterization and interventional cardiology. J Am Coll Cardiol. 2005;46:1388-90. (Pubitemid 41615572)
306. Bacha EA, Hijazi ZM. Hybrid procedures in pediatric cardiac surgery. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2005;78-85. (Pubitemid 40468457)
307. Galantowicz M, Cheatham JP, Phillips A, et al. Hybrid approach for hypoplastic left heart syndrome: intermediate results after the learning curve. Ann Thorac Surg. 2008;85:2063-70.
308. Bergersen L, Gauvreau K, Jenkins KJ, et al. Adverse event rates in congenital cardiac catheterization: a new understanding of risks. Congenit Heart Dis. 2008;3:90-105. (Pubitemid 351467911)
309. Bergersen L, Marshall A, Gauvreau K, et al. Adverse event rates in congenital cardiac catheterization: a multi-center experience. Catheter Cardiovasc Interv. 2010;75:389-400.
310. Mehta R, Lee KJ, Chaturvedi R, et al. Complications of pediatric cardiac catheterization: a review in the current era. Catheter Cardiovasc Interv. 2008;72:278-85.
311. Vitiello R, McCrindle BW, Nykanen D, et al. Complications associated with pediatric cardiac catheterization. J Am Coll Cardiol. 1998;32:1433-40. (Pubitemid 28522406)
312. Allen HD, Mullins CE. Results of the Valvuloplasty and Angioplasty of Congenital Anomalies Registry. Am J Cardiol. 1990;65:772-4. (Pubitemid 20093401)
313. Allan CK, Thiagarajan RR, Armsby LR, et al. Emergent use of extracorporeal membrane oxygenation during pediatric cardiac catheterization. Pediatr Crit Care Med. 2006;7:212-9. (Pubitemid 43778587)